2 terminated, 1 completed, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Susan Smyth: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis Platelet transfusion, Saline - Sepsis, Thrombocytopenia | Not applicable | Withdrawn | Susan Smyth | 2017-01-03 | 2021-07-28 | |
| Dietary Sources of Lysophospholipids Obesity, Cardiovascular Risk Factor | Terminated | Susan Smyth | 44 | 2015-07-14 | 2021-07-21 | |
| XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis rivaroxaban, warfarin - Pulmonary Embolism, Venous Thrombosis | Phase 4 | Terminated | Susan Smyth | 10 | 2015-07-01 | 2018-09-27 |
| Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions rosuvastatin, placebo - Acute Coronary Syndrome, Angioplasty, Transluminal, Percutaneous Coronary | Phase 1 | Completed | Susan Smyth | 54 | 2011-06-01 | 2017-03-28 |
Acute Coronary Syndrome (1) · Focal cortical dysplasia of Taylor (1) · Hyperlipidemias (1) · Obesity (1) · Pulmonary Embolism (1) · Sepsis (1) · Thrombocytopenia (1) · Venous Thrombosis (1)
Platelet Transfusion (1) · Rivaroxaban (1) · Rosuvastatin Calcium (1) · Sodium Chloride (1) · Warfarin (1)
United States (3)
Susan S Smyth, MD PhD (2) · Susan S Smyth, MD, PhD (2)